跳至主要内容
临床试验/ACTRN12613000141741
ACTRN12613000141741终止未知

In pregnant women, is the use of the Odon device during the second stage of labour feasible and safe for maternal and perinatal outcomes?

World Health Organization0 个研究点目标入组 130 人开始时间: 2013年2月6日最近更新:
适应症

试验速览

阶段
未知
状态
终止
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 35 Years(—)
性别
Female

入选标准

  • Age more or equal to 18 years, and less or equal 35 years
  • - Singleton pregnancy
  • - Gestational age equal to or more than 37 weeks
  • - Live fetus
  • - Fully dilated cervix
  • - Membranes ruptured (spontaneous or artificial).
  • - Any anterior occiput presentation.
  • - Station level equivalent to 2 cm or more below the spines
  • - Fetal Heart Rate Pattern recorded by continuous fetal electronic monitoring meeting the following criteria: (i) stable baseline rate between 110 and 160 beats/min, (ii) normal short and long term variability, (iii) absence of late decelerations.

排除标准

  • - Suspected or confirmed maternal infection
  • - Prolonged rupture of membranes (>24 hours)
  • - Meconium stained
  • - History of coagulation disorder
  • - Previous uterine surgery
  • - Intrapartum hemorrhage
  • - Absolute cephalopelvic disproportion
  • - Known recto-vaginal Streptoccocus B Haemolyticcus positive culture
  • - Known HIV positive women

研究者

相似试验